Home
About
Portfolio
Meet the Team
News
Contact
Investor Portal

info@chv.vc
129 South Street, 4th Floor, Boston, MA 02111

Home / Portfolio / EyeCool Therapeutics

EyeCool Therapeutics

EyeCool Therapeutics is developing a novel device-based solution for the treatment of dry eye.

Status

Active

CHV Lead

Joshua Phillips

Related News & Links

EyeCool Therapeutics Announces Promising Results from Double-Masked Randomized Controlled Trial in Chronic Ocular Surface Pain (COSP)

May 7, 2025

Let’s Connect.

Sitemap

Home
About
Portfolio
Meet the Team
News
Contact
Investor Portal

About

Catalyst Health Ventures (CHV) is a venture capital fund investing in transformative medical technologies addressing global unmet needs.

Contact

info@chv.vc

Boston Web Design by GoingClear